Ovid Therapeutics Inc. (OVID) Financials
OVID Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 144.0 million | 56.2 million |
2023-09-30 | 125.0 million | 23.7 million |
2023-06-30 | 136.2 million | 25.5 million |
2023-03-31 | 143.4 million | 22.4 million |
OVID Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -11.9 million | 1.8 million |
2023-09-30 | -10.1 million | 1.6 million |
2023-06-30 | -11.8 million | 1.9 million |
2023-03-31 | -12.1 million | 1.9 million |
OVID Net Income
No data available :(
OVID Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 105.8 million | - | 16.0 million |
2023-09-30 | 87.1 million | - | 16.3 million |
2023-06-30 | 96.5 million | - | 16.3 million |
2023-03-31 | 117.7 million | - | 16.5 million |
OVID Shares Outstanding
OVID Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1216 | 10.5 million | 7.7 million | 300997 |
2023-09-30 | 5245 | 5.3 million | 6.8 million | - |
2023-06-30 | 117434 | 6.0 million | 8.2 million | - |
2023-03-31 | 13560 | 6.6 million | 8.3 million | - |
OVID Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 141562 | 401392 |
2023-09-30 | 108972 | -108.9 million |
2023-06-30 | 75000 | -74.9 million |
2023-03-31 | 66160 | -66.1 million |
OVID
Price: $3.06
52 week price:
Earnings Per Share: -0.74 USD
P/E Ratio: -5.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 61100
Ebitda: -9.4 millionMarket Capitalization: 229.8 million